2,4-thiazolidinedione has been researched along with Leucocythaemia in 2 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patil, V | 1 |
| Tilekar, K | 1 |
| Mehendale-Munj, S | 1 |
| Mohan, R | 1 |
| Ramaa, CS | 1 |
| Liu, K | 1 |
| Guo, TL | 1 |
| Hait, NC | 1 |
| Allegood, J | 1 |
| Parikh, HI | 1 |
| Xu, W | 1 |
| Kellogg, GE | 1 |
| Grant, S | 1 |
| Spiegel, S | 1 |
| Zhang, S | 1 |
2 other studies available for 2,4-thiazolidinedione and Leucocythaemia
| Article | Year |
|---|---|
Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives.
Topics: Antineoplastic Agents; Benzylidene Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation | 2010 |
Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Humans; Leukemia; Models, Molecular; Phosphotr | 2013 |